In recent weeks, Asian markets have shown resilience despite global economic uncertainties, with indices reflecting a mix of cautious optimism and volatility driven by geopolitical tensions and fluctuating oil prices. In this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that offer potential for growth at discounted valuations.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name	Current Price	Fair Value (Est)	Discount (Est)
Premium Group (TSE:7199)	¥2021.00	¥3941.82	48.7%
Pan-United (SGX:P52)	SGD1.62	SGD3.14	48.4%
OVERLAP HoldingsInc (TSE:414A)	¥841.00	¥1667.62	49.6%
Lotes (TWSE:3533)	NT$1835.00	NT$3658.42	49.8%
Jiangsu Azure (SZSE:002245)	CN¥16.06	CN¥31.06	48.3%
GKG Precision Machine (SZSE:301338)	CN¥87.03	CN¥170.36	48.9%
Fuji (TSE:6134)	¥6806.00	¥13318.84	48.9%
DAEDUCK ELECTRONICS (KOSE:A353200)	₩91300.00	₩181162.91	49.6%
CanSino Biologics (SEHK:6185)	HK$23.40	HK$45.53	48.6%
Asia Metal Industries (TPEX:6727)	NT$343.00	NT$680.46	49.6%

Click here to see the full list of 209 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Regina Miracle International (Holdings) (SEHK:2199)

Overview: Regina Miracle International (Holdings) Limited is an investment holding company that designs, manufactures, and trades intimate wear and sports products, with a market cap of HK$2.22 billion.

Operations: The company's revenue segments are comprised of HK$4.20 billion from intimate wear, HK$3.08 billion from sports products, and HK$203.08 million from consumer electronics components, along with HK$232.94 million from bra pads and other accessory products.

Estimated Discount To Fair Value: 22.1%

Regina Miracle International (Holdings) is trading at 22.1% below its estimated fair value, with a share price of HK$1.81 compared to a future cash flow value of HK$2.32, indicating it may be undervalued based on cash flows. Despite slower revenue growth forecasts than the Hong Kong market, earnings are expected to grow significantly at 31.9% annually over the next three years. Recent results show net income improvement and a proposed dividend increase, though interest coverage remains weak.

• According our earnings growth report, there's an indication that Regina Miracle International (Holdings) might be ready to expand.
• Delve into the full analysis health report here for a deeper understanding of Regina Miracle International (Holdings).

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

Overview: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a biotechnology company focused on the research and development of novel antibody-based drugs and pre-clinical research services, with a market cap of approximately HK$60.16 billion.

Operations: Biocytogen Pharmaceuticals generates revenue primarily from its research and development of novel antibody-based drugs and pre-clinical research services across China, the United States, and internationally.

Estimated Discount To Fair Value: 43.8%

Biocytogen Pharmaceuticals (Beijing) trades at HK$54.7, significantly below its estimated future cash flow value of HK$97.3, suggesting undervaluation based on cash flows. Earnings grew substantially by over 500% last year and are forecast to grow annually at 40.43%, outpacing the Hong Kong market's growth expectations. Recent legal victories affirm technology platform strength, while a global collaboration with Whitehawk Therapeutics and new AI-powered platforms bolster potential revenue streams and innovation capabilities.

• The growth report we've compiled suggests that Biocytogen Pharmaceuticals (Beijing)'s future prospects could be on the up.
• Take a closer look at Biocytogen Pharmaceuticals (Beijing)'s balance sheet health here in our report.

Food & Life Companies (TSE:3563)

Overview: Food & Life Companies Ltd. operates a chain of sushi restaurants and has a market cap of approximately ¥1.30 billion.

Operations: The company's revenue segments include the Japan Sushiro Business at ¥281.35 billion, International Sushiro Business at ¥166.68 billion, and Kyotaru Business at ¥22.76 billion.

Estimated Discount To Fair Value: 12.1%

Food & Life Companies is trading at ¥5736, below its estimated future cash flow value of ¥6529.29, indicating undervaluation. The company revised its earnings guidance upward for fiscal 2026, with revenue now expected to reach ¥505 billion and operating profit at ¥48.5 billion. A joint venture with Kyoritsu Co., Ltd., focused on sustainable marine resources, aligns with strategic growth initiatives and enhances its international presence in the food industry.

• Our earnings growth report unveils the potential for significant increases in Food & Life Companies' future results.
• Click to explore a detailed breakdown of our findings in Food & Life Companies' balance sheet health report.

Turning Ideas Into Actions

• Delve into our full catalog of 209 Undervalued Asian Stocks Based On Cash Flows here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.